A Prospective Clinical Outcomes Registry (PAIN Registry)
This study is ongoing, but not recruiting participants.
Sponsor:
Advanced Neuromodulation Systems
Information provided by (Responsible Party):
Advanced Neuromodulation Systems
ClinicalTrials.gov Identifier:
NCT01305525
First received: February 25, 2011
Last updated: October 9, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a prospective non-interventional 24 month post implant registry. Any patient that receives a St. Jude Medical FDA approved implantable neuromodulation system is eligible for enrollment. A minimum of 600 patients will be enrolled from a minimum of 30 sites.
Patients will be enrolled post-implant and followed for 24 months. Data are collected at enrollment (within 30 days of device implant), and routine care follow-up visits at 3 months, 6 months, 12 months, 18 months and 24 months.
| Condition | Intervention |
|---|---|
|
Pain |
Device: St. Jude Medical Spinal Cord Stimulation Systems |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Partnership for Advancement In Neuromodulation (PAIN): A Prospective Clinical Outcomes Registry |
Further study details as provided by Advanced Neuromodulation Systems:
| Estimated Enrollment: | 600 |
| Study Start Date: | June 2009 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Spinal Cord Stimulation |
Device: St. Jude Medical Spinal Cord Stimulation Systems
Spinal cord stimulation
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Patients implanted with a neuromodulation system
Criteria
Inclusion Criteria:
- Patient has signed and received a copy of the Informed Consent form;
- Patient has been implanted with a St. Jude Medical Neuromodulation system, including battery and/or SCS leads;
- Patient is 18 years of age or older.
- Patient is not currently participating in another clinical trial.
Exclusion Criteria:
- None
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01305525
Show 32 Study Locations
Show 32 Study LocationsSponsors and Collaborators
Advanced Neuromodulation Systems
More Information
No publications provided
| Responsible Party: | Advanced Neuromodulation Systems |
| ClinicalTrials.gov Identifier: | NCT01305525 History of Changes |
| Other Study ID Numbers: | C-09-01 |
| Study First Received: | February 25, 2011 |
| Last Updated: | October 9, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Advanced Neuromodulation Systems:
|
SCS St. Jude Medical Neuromodulation |
ClinicalTrials.gov processed this record on June 18, 2013